Carmustine wafer implantation at the era of standardized chemoradiation protocol

Alexandre Rou; Marc Zanello; Gilles Zah-Bi; Johan Pallud

doi:10.4103/ajns.AJNS_297_18

Asian Journal of Neurosurgery, Table of Contents

CC BY-NC-ND 4.0 · Asian J Neurosurg 2019; 14(02): 616-617
DOI: 10.4103/ajns.AJNS_297_18

Letter to Editor

Carmustine wafer implantation at the era of standardized chemoradiation protocol

Authors

Alexandre Rou

¹Department of Neurosurgery, Sainte-Anne Hospital Center

²Department of Neurosurgery, Paris Descartes University, Sorbonne Paris Cité

³IMABRAIN, Institute of Psychiatry and Neurosciences of Paris, Paris
Marc Zanello

¹Department of Neurosurgery, Sainte-Anne Hospital Center

²Department of Neurosurgery, Paris Descartes University, Sorbonne Paris Cité

³IMABRAIN, Institute of Psychiatry and Neurosciences of Paris, Paris
Gilles Zah-Bi

¹Department of Neurosurgery, Sainte-Anne Hospital Center
Johan Pallud

¹Department of Neurosurgery, Sainte-Anne Hospital Center

²Department of Neurosurgery, Paris Descartes University, Sorbonne Paris Cité

³IMABRAIN, Institute of Psychiatry and Neurosciences of Paris, Paris

Abstract

Full Text

References

References
1 Salle F, Lahiani W, Spagnuolo E, Palfi S. Adverse event with the use of carmustine wafers and postoperative radiochemotherapy for the treatment of high-grade glioma. Asian J Neurosurg 2018;13:1171-4.
2 Roux A, Caire F, Guyotat J, Menei P, Metellus P, Pallud J, et al. Carmustine wafer implantation for high-grade gliomas: Evidence-based safety efficacy and practical recommendations from the neuro-oncology club of the French society of neurosurgery. Neurochirurgie 2017;63:433-43.
3 Bock HC, Puchner MJ, Lohmann F, Schütze M, Koll S, Ketter R, et al. First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: A multicenter experience. Neurosurg Rev 2010;33:441-9.
4 Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K, et al. Chemotherapeutic wafers for high grade glioma. Cochrane Database Syst Rev 2008;CD007294.
5 Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K, et al. Chemotherapy wafers for high grade glioma. Cochrane Database Syst Rev 2011;CD007294.
6 Chowdhary SA, Ryken T, Newton HB. Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: A meta-analysis. J Neurooncol 2015;122:367-82.
7 Ashby LS, Smith KA, Stea B. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: A systematic literature review. World J Surg Oncol 2016;14:225.
8 Duntze J, Litré CF, Eap C, Théret E, Debreuve A, Jovenin N, et al. Implanted carmustine wafers followed by concomitant radiochemotherapy to treat newly diagnosed malignant gliomas: Prospective, observational, multicenter study on 92 cases. Ann Surg Oncol 2013;20:2065-72.
9 Menei P, Metellus P, Parot-Schinkel E, Loiseau H, Capelle L, Jacquet G, et al. Biodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: The French experience. Ann Surg Oncol 2010;17:1740-6.
10 Pallud J, Audureau E, Noel G, Corns R, Lechapt-Zalcman E, Duntze J, et al. Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: A controlled propensity-matched analysis of a French multicenter cohort. Neuro Oncol 2015;17:1609-19.
11 Pavlov V, Page P, Abi-Lahoud G, Nataf F, Dezamis E, Robin A, et al. Combining intraoperative carmustine wafers and stupp regimen in multimodal first-line treatment of primary glioblastomas. Br J Neurosurg 2015;29:524-31.